Pediatric Extracorporeal Membrane Oxygenation Anticoagulation Protocol Associated with a Decrease in Complications

Area of Science:

• Pediatric critical care medicine
• Cardiovascular surgery
• Hematology

Background:

• Extracorporeal membrane oxygenation (ECMO) is a life-saving therapy for critically ill children.
• Anticoagulation management during pediatric ECMO is complex and varies significantly.
• Standardized protocols are needed to mitigate complications like thrombosis and bleeding.

Purpose of the Study:

• To evaluate the impact of a standardized anticoagulation protocol on pediatric ECMO patients.
• To assess changes in clotting and bleeding complications after protocol implementation.
• To analyze differences in laboratory values and blood product use between pre- and post-protocol groups.

Main Methods:

• Single-center retrospective analysis of pediatric ECMO cases (2014-2018).
• Comparison of 64 pre-protocol cases with 37 post-protocol cases.
• Analysis of demographics, ECMO parameters, complications, labs, and blood product requirements.

Main Results:

• Significant reduction in hematologic, neurologic, and renal complications post-protocol.
• No significant difference in bleeding, cardiac/pulmonary complications, or circuit changes.
• Fewer red blood cell and cryoprecipitate transfusions required in the post-protocol group.
• Higher platelet counts and fibrinogen levels maintained post-protocol.

Conclusions:

• Implementation of a standardized anticoagulation protocol improved outcomes in pediatric ECMO.
• The protocol led to better anticoagulation control, reduced complications, and decreased blood product administration.
• Transitioning to anti-Xa monitoring and maintaining higher platelet counts were key factors.